Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp. - common stock
(NQ:
PROF
)
7.330
-0.040 (-0.54%)
Streaming Delayed Price
Updated: 1:44 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Profound Medical Corp. - common stock
< Previous
1
2
3
4
5
Next >
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
October 17, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
October 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
September 20, 2024
Via
ACCESSWIRE
Profound Medical: Q4 Earnings Insights
↗
March 07, 2024
Via
Benzinga
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
September 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
September 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024
↗
August 08, 2024
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Profound Medical Announces Second Quarter 2024 Financial Results
August 08, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
July 18, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
July 16, 2024
Via
Benzinga
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
July 11, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General Meeting of Shareholders Voting Results
May 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 14, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
↗
May 09, 2024
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
May 06, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
April 22, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
↗
March 07, 2024
PROF stock results show that Profound Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering
January 04, 2024
Via
Investor Brand Network
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
January 03, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday
↗
December 28, 2023
With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
